Omolola Salako is a medical oncologist and the Founder and Chief Executive Officer of Sebeccly Cancer Care, Oncopadi Technologies, and Pearl Oncology Specialist Hospital, playing a central role in shaping Nigeria’s modern cancer care ecosystem across prevention, digital health, and specialized clinical services. Through Sebeccly, she has led the expansion of large-scale cancer awareness and screening programs, supporting the screening of tens of thousands of women and providing navigation and support for thousands of patients undergoing cancer treatment. Her public-facing advocacy initiatives, including mass-participation awareness campaigns, have significantly elevated breast cancer awareness and early detection in Nigeria.
Beyond nonprofit advocacy, Dr. Salako has built integrated care delivery models that connect technology with clinical oncology. She founded Oncopadi, one of Africa’s first digital oncology platforms, using telemedicine and patient navigation to improve access to specialist care for underserved populations. In parallel, she has developed Pearl Oncology Specialist Hospital into an expanding provider of chemotherapy, surgery, and multidisciplinary cancer services. Her leadership has been recognized internationally, including receiving the UICC Best CEO Award and the ASCO International Innovation Grant, reflecting her contribution to scalable, patient-centered oncology models in low- and middle-income settings.
The 100 CEOs featured here reflect the diversity and complexity of modern oncology leadership. In 2025, some lead the world’s largest cancer institutions; others guide specialized societies or emerging innovators. What unites them is responsibility: for millions of patients, for the integrity of science, and for the future direction of cancer care globally.
This list is not a celebration of power, but a recognition of stewardship, accountability, and impact – and of the leaders whose choices continue to shape the fight against cancer. For the many deserving individuals not mentioned in this list, we will continue to acknowledge, honor and elevate your voices in our daily publications from across the world.
See the full list of The 100 Influential CEOs in Oncology in 2025 and stay tuned for other special category nominations
